#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLfellows: Lorenzo Torreni / Elisabet Munté

Gut microbiota in X-ALD patients: an overlooked player on the field? Lorenzo Torreni – Neurometabolic diseases Group…

Read More

#IDIBELLseminars – Seeing is Believing: Visualising the Heterogeneous Metabolism of Breast Cancer

Tumours undergo constant Darwinian evolution and clonal diversification, the net result of which tends to be increased…

Read More

Pint of Science 2024: Cómo luchar contra las arrugas del pulmón?

Envejecemos a partir de los 40-50 años (algunos incluso antes). Cuando nos miramos en el espejo percibimos…

Read More

#IDIBELLfellows: Iswarya Sreeram / Ana Cantos Cortes

From Senescence to cell death: exploring novel therapeutic approaches in Malignant Pleural Mesothelioma (MPM) Iswarya Sreeram –…

Read More

#IDIBELLseminars: Paper mills and predatory journals: emerging forms of scientific misconduct

Research misconduct is an understudied topic. Behind the classic publish or perish axiom, there are multiple and…

Read More

ONCOBELL 3rd International Symposium

New frontiers in cancer therapies and personalized medicine Barcelona, October 3rd – 4th, 2024 Venue: Auditorium HUB…

Read More

Dia internacional de les infermeres

13 de maig a les 15.30 h | Sala d’Actes de l’Hospital Universitari de Bellvitge Jornada acreditada…

Read More

IX EMDebate

Us presentem el programa de l’edició EMDebate d’enguany.  Hem convidat a alguns dels principals especialistes en esclerosi…

Read More

Programa de actualización en esclerosis múltiple

Des de la Unitat d’Esclerosi Múltiple EMxarxa us presentem el programa de sessions “Actualización en Esclerosis Múltiple”,…

Read More

#IDIBELLseminars: Targeting lineage plasticity in prostate cancer

Drug resistance in cancer is often linked to changes in tumor cell state or lineage, but the…

Read More
Scroll to Top